Related Experiment Video
Updated: Jul 19, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Molecular Mechanism Pathways of Natural Compounds for the Treatment of Non-Alcoholic Fatty Liver Disease
Xiaolei Fang1, Jiayu Song1, Kaixuan Zhou1
1College of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
Abstract:
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the world, and its incidence continues to increase each year. Yet, there is still no definitive drug that can stop its development. This review focuses mainly on lipotoxicity, oxidative stress, inflammation, and intestinal flora dysbiosis to understand NAFLD's pathogenesis. In this review, we used NCBI's PubMed database for retrieval, integrating in vivo and in vitro experiments to reveal the therapeutic effects of natural compounds on NAFLD. We also reviewed the mechanisms by which the results of these experiments suggest that these compounds can protect the liver from damage by modulating inflammation, reducing oxidative stress, decreasing insulin resistance and lipid accumulation in the liver, and interacting with the intestinal microflora. The natural compounds discussed in these papers target a variety of pathways, such as the AMPK pathway and the TGF-β pathway, and have significant therapeutic effects. This review aims to provide new possible therapeutic lead compounds and references for the development of novel medications and the clinical treatment of NAFLD. It offers fresh perspectives on the development of natural compounds in preventing and treating NAFLD.
Insights
Natural compounds show promise for treating non-alcoholic fatty liver disease (NAFLD), a widespread condition lacking effective drugs. This review explores how these compounds combat NAFLD by targeting inflammation, oxidative stress, and gut health.
Area of Science:
- Hepatology
- Pharmacology
- Natural Product Chemistry
Background:
- Non-alcoholic fatty liver disease (NAFLD) is a global health concern with increasing prevalence.
- Current therapeutic options for NAFLD are limited, highlighting the need for novel treatment strategies.
Purpose of the Study:
- To review the therapeutic potential of natural compounds for NAFLD.
- To elucidate the mechanisms underlying the protective effects of natural compounds against NAFLD pathogenesis.
Main Methods:
- Systematic literature search of the PubMed database.
- Integration of in vivo and in vitro experimental findings on natural compounds and NAFLD.
- Analysis of molecular pathways targeted by natural compounds.
Main Results:
- Natural compounds demonstrate efficacy in mitigating NAFLD by reducing hepatic lipotoxicity, oxidative stress, and inflammation.
- Compounds modulate key pathways, including AMPK and TGF-β, improving insulin resistance and lipid accumulation.
- Interactions with the gut microbiota are identified as a significant mechanism of action.
Conclusions:
- Natural compounds offer a promising avenue for NAFLD prevention and treatment.
- Further research into these compounds can lead to the development of novel therapeutic agents for NAFLD.
- This review provides a foundation for future drug development and clinical applications in NAFLD management.
Related Concept Videos
Overview of Fatty Acid Metabolism
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

